The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma
仑伐替尼的分子相互作用模式能够抑制野生型或激酶突变的 FGFR2 驱动的胆管癌
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-024-45247-6
Stephan Spahn #, Fabian Kleinhenz #, Ekaterina Shevchenko, Aaron Stahl, Yvonne Rasen, Christine Geisler, Kristina Ruhm, Marion Klaumuenzer, Thales Kronenberger, Stefan A Laufer, Holly Sundberg-Malek, Khac Cuong Bui, Marius Horger, Saskia Biskup, Klaus Schulze-Osthoff, Markus Templin, Nisar P Malek,